The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis.
Cardiac amyloidosis
Cardiac imaging
Diagnosis
Scintigraphy
Journal
Heart failure clinics
ISSN: 1551-7136
Titre abrégé: Heart Fail Clin
Pays: United States
ID NLM: 101231934
Informations de publication
Date de publication:
Jul 2024
Jul 2024
Historique:
medline:
7
6
2024
pubmed:
7
6
2024
entrez:
6
6
2024
Statut:
ppublish
Résumé
Cardiac amyloidosis (CA) is caused by the myocardial deposition of misfolded proteins, either amyloid transthyretin (ATTR) or immunoglobulin light chains (AL). The paradigm of this condition has transformed, since CA is increasingly recognized as a relatively prevalent cause of heart failure. Cardiac scintigraphy with bone tracers is the unique noninvasive technique able to confirm CA without performing tissue biopsy or advanced imaging tests. A moderate-to-intense myocardial uptake (Perugini grade ≥2) associated with the absence of a monoclonal component is greater than 99% specific for ATTR-CA, while AL-CA confirmation requires tissue biopsy.
Identifiants
pubmed: 38844301
pii: S1551-7136(24)00019-9
doi: 10.1016/j.hfc.2024.03.003
pii:
doi:
Substances chimiques
Radiopharmaceuticals
0
Prealbumin
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
307-316Informations de copyright
Copyright © 2024 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure None. Funding: none.